LP247941-0
Lobular carcinoma in situ
Active
Description
Lobular carcinoma in situ (LCIS) is part of the category of breast diseases called lobular neoplasia. LCIS is associated with an eight- to ten-fold increased risk of developing breast cancer in either breast, not only the one where the LCIS was discovered. Treatment options for women with LCIS include lifelong monitoring in order to detect future possible malignancy at an early stage, chemoprevention, and bilateral prophylactic mastectomy. PMID: 22106556 Source: Regenstrief LOINC
Basic Part Properties
- Part Display Name
- LCIS
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2017-01-26
- Construct for LOINC Short Name
- LCIS
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP247941-0
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-ES | Spanish (Spain) | Carcinoma lobulillar in situ |
| zh-CN | Chinese (China) | 小叶原位癌 Synonyms: LCIS; |
| it-IT | Italian (Italy) | Carcinoma lobulare in situ Synonyms: LCIS |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright